Title : The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.

Pub. Date : 2014 Jul

PMID : 24697238






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach. ibrutinib Bruton tyrosine kinase Homo sapiens
2 Bruton tyrosine kinase (BTK), a key player in BCR signalling, as well as B cell migration and adhesion, can be targeted with ibrutinib, a selective, irreversible BTK inhibitor. ibrutinib Bruton tyrosine kinase Homo sapiens
3 Bruton tyrosine kinase (BTK), a key player in BCR signalling, as well as B cell migration and adhesion, can be targeted with ibrutinib, a selective, irreversible BTK inhibitor. ibrutinib Bruton tyrosine kinase Homo sapiens
4 Bruton tyrosine kinase (BTK), a key player in BCR signalling, as well as B cell migration and adhesion, can be targeted with ibrutinib, a selective, irreversible BTK inhibitor. ibrutinib Bruton tyrosine kinase Homo sapiens